Small-molecule modulators of 14-3-3 protein-protein interactions

被引:38
作者
Ottmann, Christian [1 ,2 ]
机构
[1] Tech Univ Eindhoven, Dept Biomed Engn, Biol Chem Lab, NL-5612 AZ Eindhoven, Netherlands
[2] Max Planck Gesell, Chem Genom Ctr, D-44227 Dortmund, Germany
关键词
PPI inhibitors; PPI stabilizers; Protein-protein interactions; Drug development; Chemical biology; COTYLENIN-A; LEUKEMIA-CELLS; EXOENZYME-S; RAF; 14-3-3-PROTEINS; IDENTIFICATION; BINDING; DIFFERENTIATION; INHIBITORS; STABILIZATION;
D O I
10.1016/j.bmc.2012.11.028
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
14-3-3 Proteins are eukaryotic adapter proteins that regulate a plethora of physiological processes by binding to several hundred partner proteins. They play a role in biological activities as diverse as signal transduction, cell cycle regulation, apoptosis, host-pathogen interactions and metabolic control. As such, 14-3-3s are implicated in disease areas like cancer, neurodegeneration, diabetes, pulmonary disease, and obesity. Targeted modulation of 14-3-3 protein-protein interactions (PPIs) by small molecules is therefore an attractive concept for disease intervention. In recent years a number of examples of inhibitors and stabilizers of 14-3-3 PPIs have been reported promising a vivid future in chemical biology and drug development for this remarkable class of proteins. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4058 / 4062
页数:5
相关论文
共 56 条
  • [1] 14-3-3 proteins: A historic overview
    Aitken, Alastair
    [J]. SEMINARS IN CANCER BIOLOGY, 2006, 16 (03) : 162 - 172
  • [2] A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged high-throughput biophysical screening
    An, Steven S.
    Askovich, Peter S.
    Zarembinski, Thomas I.
    Ahn, Kwangmi
    Peltier, John M.
    von Rechenberg, Moritz
    Sahasrabudhe, Sudhir
    Fredberg, Jeffrey J.
    [J]. RESPIRATORY RESEARCH, 2011, 12
  • [3] The 14-3-3ζ-GPM-IX-V complex as an antiplatelet target
    Andrews, Robert K.
    Du, Xiaoping
    Berndt, Michael C.
    [J]. DRUG NEWS & PERSPECTIVES, 2007, 20 (05) : 285 - 292
  • [4] Synthesis of a Phosphoserine Mimetic Prodrug with Potent 14-3-3 Protein Inhibitory Activity
    Arrendale, Allison
    Kim, Keunho
    Choi, Jun Young
    Li, Wei
    Geahlen, Robert L.
    Borch, Richard F.
    [J]. CHEMISTRY & BIOLOGY, 2012, 19 (06): : 764 - 771
  • [5] FUSICOCCIN - NEW WILTING TOXIN PRODUCED BY FUSICOCCUM AMYGDALI DEL
    BALLIO, A
    MAURI, M
    CHAIN, EB
    DELEO, P
    TONOLO, A
    ERLANGER, BF
    [J]. NATURE, 1964, 203 (494) : 297 - &
  • [6] 14-3-3 proteins in the nervous system
    Berg, D
    Holzmann, C
    Riess, O
    [J]. NATURE REVIEWS NEUROSCIENCE, 2003, 4 (09) : 752 - 762
  • [7] A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX
    BROWN, EJ
    ALBERS, MW
    SHIN, TB
    ICHIKAWA, K
    KEITH, CT
    LANE, WS
    SCHREIBER, SL
    [J]. NATURE, 1994, 369 (6483) : 756 - 758
  • [8] Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice
    Cao, Weidong
    Yang, Xiaoliang
    Zhou, Jie
    Teng, Zenghui
    Cao, Lei
    Zhang, Xiang
    Fei, Zhou
    [J]. APOPTOSIS, 2010, 15 (02) : 230 - 241
  • [9] 14-3-3-PROTEINS ASSOCIATE WITH CDC25-PHOSPHATASES
    CONKLIN, DS
    GALAKTIONOV, K
    BEACH, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7892 - 7896
  • [10] Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: The 14-3-3σ case
    Corradi, Valentina
    Mancini, Manuela
    Santucci, Maria Alessandra
    Carlomagno, Teresa
    Sanfelice, Domenico
    Mori, Mattia
    Vignaroli, Giulia
    Falchi, Federico
    Manetti, Fabrizio
    Radi, Marco
    Botta, Maurizio
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (22) : 6867 - 6871